[Management of heart insufficiency using alpha-acetyldigoxin].
D000818:Animals; D001022:Aortic Valve Insufficiency / Q000150:complications; D001024:Aortic Valve Stenosis / Q000150:complications; D001835:Body Weight / Q000187:drug effects; D010856:Columbidae; D003327:Coronary Disease / Q000150:complications; D004074:Digitoxin / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006344:Heart Septal Defects, Atrial / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D006980:Hyperthyroidism / Q000150:complications; D008946:Mitral Valve Stenosis / Q000150:complications; D010494:Pericarditis, Constrictive / Q000150:complications; D011660:Pulmonary Heart Disease / Q000150:complications
D004074:Digitoxin
Behandlung der Herzinsuffizienz mit alpha-Azetyldigoxin.